Glioblastoma (GBM) is the most common and aggressive type of primary brain cancer. With median survival of less than 15 months, identification and validation of new GBM therapeutic targets is of critical importance. | Expression and activity of the calcitonin receptor family in a sample of primary human high-grade gliomas